Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide

被引：0
|
作者：
Schuelper, Nikolai [1 ]
Flohr, Antonius [2 ]
Truemper, Lorenz [1 ]
Wulf, Gerald G. [1 ]
机构：
[1] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Dept Radiol, D-37075 Gottingen, Germany
来源：
ANNALS OF HEMATOLOGY | 2014年 / 93卷 / 11期
关键词：
MONOTHERAPY;
D O I：
10.1007/s00277-014-2071-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1929 / 1930
页数：2
相关论文
共 50 条
  • [1] Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide
    Nikolai Schuelper
    Antonius Flohr
    Lorenz Trümper
    Gerald G. Wulf
    Annals of Hematology, 2014, 93 : 1929 - 1930
  • [2] Diffuse large B-cell lymphoma presenting with osteolytic lesions in the bilateral femur
    Funato, Michinori
    Kato, Hiroki
    Sasai, Hideo
    Kubota, Kazuo
    Ozeki, Michio
    Kato, Zenichiro
    Kaneko, Hideo
    Fukao, Toshiyuki
    Kondo, Naomi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (05) : 502 - 502
  • [3] Late relapse in patients with diffuse large B-cell lymphoma
    Vose, Julie M.
    Weisenburger, Dennis D.
    Loberiza, Fausto R.
    Arevalo, Alejandro
    Bast, Martin
    Armitage, Joel
    Bierman, Philip J.
    Bociek, Robert G.
    Armitage, James O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) : 354 - 358
  • [4] Clinical Outcomes for Patients with Diffuse Large B-cell Lymphoma Treated with Radiation Therapy and Lenalidomide
    Kim, Sungjune
    Shah, Shreni
    Yu, Su-Yuan
    Mills, Matthew
    Figura, Nicholas
    Robinson, Timothy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S112 - S112
  • [5] The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma
    Palmieri, R.
    Esposito, F.
    Meconi, F.
    Rapisarda, V. M.
    Anemona, L.
    Paterno, G.
    Vaccarini, S.
    Nasso, D.
    Pupo, L.
    Cantonetti, M.
    CASE REPORTS IN HEMATOLOGY, 2019, 2019
  • [6] The gut microbiota is altered significantly in primary diffuse large b-cell lymphoma patients and relapse refractory diffuse large b-cell lymphoma patients
    Xu, Yu
    Shi, Chang
    Qian, Jiejing
    Yu, Xiao
    Wang, Shasha
    Shao, Li
    Yu, Wenjuan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [7] Lenalidomide and Temozolomide Combination in a Very Elderly Patient with CNS Relapse of Diffuse Large B-Cell Lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Arrigucci, Umberto
    Cerase, Alfonso
    Bocchia, Monica
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [8] Prognostic Value of Time of Relapse in Patients With Diffuse Large B-Cell Lymphoma
    Mabed, Mohamed
    Amir, May
    El-Ashwah, Shaimaa
    Azmy, Emad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S417 - S417
  • [9] Stensen Duct Relapse of Diffuse Large B-Cell Lymphoma
    Sharma, Punit
    Bhartia, Shilpa
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (07) : 573 - 574
  • [10] Where Does Diffuse Large B-Cell Lymphoma Relapse?
    Adams, Hugo J. A.
    de Klerk, John M. H.
    Fijnheer, Rob
    Heggelman, Ben G. F.
    Dubois, Stefan V.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2016, 40 (04) : 531 - 536
12345